President Donald Trump walks past HHS secretary Alex Azar (Saul Loeb/AFP via Getty Images)

Trump of­fi­cials said in­dus­try did­n't want FDA's stricter vac­cine guid­ance, but the lead­ing de­vel­op­er says they nev­er dis­cussed it

There are four weeks to the elec­tion. Se­nior Trump of­fi­cials are now cit­ing in­dus­try op­po­si­tion as the rea­son they are block­ing the FDA from mak­ing of­fi­cial their pro­posed EUA+ vac­cine guide­lines, which, if en­forced, would dim the pos­si­bil­i­ty of a pre-Elec­tion Day ap­proval.

These rev­e­la­tions come from a pair of new re­ports out last night from the New York Times and Politi­co. But al­most as soon as they came out, in­dus­try in­sid­ers be­gan push­ing back on the al­le­ga­tions. For­mer FDA chief Scott Got­tlieb said he had nev­er heard in any­one in phar­ma ex­press that view, and Pfiz­er CEO Al­bert Bourla said he had nev­er dis­cussed the is­sue with the White House.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.